The purpose of these studies was to develop a high performance liquid Chromatographie (HPLC) assay for plasma levels of indomethacin. A reversed phase (C 18 Sep-Pak) cartridge was used to process plasma for absorption of indomethacin, the internal Standard, and impurities. The recovery of plasma indomethacin and the added internal Standard was quantitative from 0.5 ml of plasma. The assay was linear from 50 g/l to 10 mg/1 without concentration of the effluent from the Sep-Pak cartridge. The intra-assay coefficients of Variation, for ten injections each to calibrate points at 0.15, 0.30, 0.50 and 1.00 mg/1, were 8.15%, 6.29%, 5.47% and 5.39%, respectively and for duplicates of duplicate calibration points were 7.51%, 6.32%, 4.41%, and 2.05%, respectively. The inter-assay coefficients of Variation were 8.49%, 6.48%, 5.10%, and 2.22%, respectively. The sensitivity of the assay can be increased by a 3 -5 fold concentration of the effluent from the Sep-Pak and preliminary experiments have indicated that äs little äs 100 of starting plasma can be utilized in the assay.
Die Methode kann zur Bestimmung von Indomethacin in kleinen Plasmavolumina angewandt werden. Da C| 8 Sep-Pak-Patronen zur Entfernung von Begleitsubstanzen angewandt werden, sind Empfindlichkeit und Reproduzierbarkeit hoch, dabei Langlebigkeit und Wirksamkeit hervorragend.
Introduction
Indomethacin, a hydroxyindole derivative which inhibits the enzyme cyclo-oxygenase found in endothelial cells and platelets, is used to treat pre-term infants with patent ductus arteriosus in order to effect closure (l -5). Use of the medication is limited by its undesirable effects which include Inhibition of platelet aggregation (6) , decreased renal water clearance (7) (8) (9) (10) and displacement of protein bound circulating bilirubin (11, 12) . A rapid, reliable method for quantitation of plasma indomethacin would aid in determination of therapeutically effective levels for minimizing dosage of administered drug. The ususal method of processing serum or plasma is to precipitate protein, extract both the indomethacin and internal Standard with an organic solvent, then concentrate and assay for indomethacin by a variety of methods (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
We established a high performance liquid chromatography (HPLC) assay for indomethacin in human plasma by a method previously reported for rabbit plasma (20) . However, limited reproducibilty, suboptimal column efficiency and decreased column life occurred despite frequent column cleaning during our studies. These problems were related to residue from processed plasma samples. Therefore, we investigated the use of reversed phase (Qg Sep-Pak) cartridges for processing plasma samples before HPLC analysis of indomethacin. This Step allowed excellent reproducibility in the quantitation of indomethacin and markedly increased column efficiency and life with less frequent column cleaning.
Experimental

Materials
All solvents, including those used for sample preparation, were HPLC grade. Chemicals were of the highest purity available and purchased from either Fisher Scientific or American Scientific Products. All reagents were filtered through 0.22 μιη Millipore filters and degassed before use. The indomethacin and the internal Standard l-0?-fluorobenzoyl)-5-methoxy-2-methylindole acetic acid were obtained from Dr. Morton Rosenberg and Dr. Clement Stone (Merck, Sharp and Dohme Research Laboratories). The Sep-Pak C 18 cartridges (three different lot nurabers) were purchased from Waters Inc.
A Beckman HPLC model 344 with two 112 pumps and a model 421 Controller was used for analysis of samples. The components of the processed plasma samples were separated using a C 18 Ultrasphere ODS Reversed Phase Column (4.6 mm χ 150 mm, Beckman) and a Precolumn (4.6 mm χ 25 mm, Beckman) each packed with 5 μιη particles. A 20 μΐ sample injector loop was used with a model 160 absorbance detector (Beckman) at 254 nm. A strip chait reoorder (Kipp and Zonen) was used for peak height concentration while an integr tor (Spectra-Physics SP4270) with the following settings was used to quantitate areas: Chart Speed (CS) == l cm/min; Peak Width (PW) = 18; Peak Threshold (PT) = 25; Integrate Inhibit (II) = 1; Disable Tailing Peak Logic (TP) = l (off); Attenuation (AT) for chart = 8 at 0.1 min; Attenuation (AT) for chart = 4 at 4.5 min; Peak Markers (PM) = l (On) at 4.5 min; Integrate Inhibit (II) = 0 (start Integration) at 4.5 min; End Run (ER) = l at 9.5 min.
Method
Plasma for the c libration curve and from study subjects was prepared by collecting blood in Venoject tubes (Terumo Medical Corp.) containing liquid potassium EDTA and potassium sorbate. Tubes were placed on wet ice and immediately subjected to centrifugation at 1200 g for 10 minutes at 4 °C. Supernatahts were divided into aliquots and stored at -70 °C until used for c libration curves or analyzed for indomethacin levels.
Indomethacin stock solution was prepared by dissolving 1.25 mg in a total of 5.00 ml methanol (final 250 mg/1) and then storing at -70 °C. A daily stock solution was prepared by diluting 50 μΐ of the freezer stock to 5.00 ml with methanol (final stock concentration 2.5 mg/1) and then storing at 4 °C. Internal Standard stock solution was prepared in the same manner s the indomethacin to btain a concentration of 250 mg/1 and stored at -70 °C. For the daily stock, 200 μΐ was diluted to 5.00 ml with methanol (final concentration of 10 mg/1). For preparation of the c libration curve, the following procedure was used: 1.0 μg of internal Standard (100 μΐ of 10 mg/1 stock) was added to 0.5 ml of plasma and then 0.50 μg, 0.25 μ& 0.15 μg or 0.075 μg (200«.uk 100 ul, 60 μΐ and 30 μΐ, respectively of 250 mg/1 stock) of indomethacin were added. Each of the four calibration curve samples was prepared in duplicate. The patient samples and calibration curve samples were processed identically and simultanepusly.
After addition of the internal Standard and indomethacin, the volume of each tube was diluted tq exactly 2.5 ml with methanol in H 2 , volume fraction 0.75. The mixture was agitated on a vortex mixer to precipitate the proteins and then spun at 1000g for 30 minutes. The supernatant was collected and acidified with 20 μΐ of glacial acetic acid and stored at -70 °C.
Further purification of the samples was achieved using C 18 SepPak cartridges. Prior to sample application, each cartridge was washed sequentially with 2 ml of methanol, 5 ml of water and 2ml of 15 ml/l acetic acid (pH 3.6). The sample -was passed through the Sep-Pak with a plastic syringe followed by addition of l ml of 15 ml/l acetic acid (pH 3.6), 2ml of acetonitrile in 0.1 mol/1 acetic acid, volume fraction 0.1 and 0.5 ml of methanol. The internal Standard and indomethacin were eluted from the cartridge with l .5 ml of methanol and collected for analysis. Accurate measurement of solvent volumes for the cartridges was critical, particularly for the methanol elutioin Step, in order to recover indomethacin and the internal Standard. Loss of liquid was minimized by laying the cartridge on its side between washes.
When processing smaller amounts of plasma (e. g. 100 μΐ or 250 μΐ), the amounts of internal Standard, methanol/H 2 O, vojume fraction 0.75 used for precipitationj and amounts of glacial acetic acid were scaled djDwn accordingly. The sample and Sep-Pak cartridges were processed äs outlined above except that the final 1.5 ml of methanol were concentrated either in an airstream under a fume hood or under vacuum.
In order to completely fill the sample loop, 40 of each processed sample were injected into the 20 sample loop for analysis. A mobile phase of 45: 55, 0.1 mol/1 acetic acid : acetonitrile with a flow rate of l ml/min was used (20) . The sensitivity was set at 0.020 absorbance units füll scale with detector wavelength at 254 nm.
A calibration curve was derived by plotting the ratio of the area of the indomethacin peak/area of the internal Standard peak versus the mg/1 of indomethacin added to each Standard. The amount of indomethacin in each patient sample was determined in duplicate from the area ratios obtained.
The recoveries of both indomethacin and the Standard were calculated by adding the amount present at each calibration point to a total volume of 1.5 ml of methanol. The area counts were then compared directly with the area counts obtained in the 1.5 ml of methanol from Sep-Pak after processing plasma calibration curve Standards.
The identification of indomethacin and the internal Standard was verified in the following procedures. Methanol containing indomethacin and internal Standard was injected into the Chromatograph in order to obtain the retention times each day. Furthermore, during development of the assay, plasma samples used for calibration curves were diluted with an equal volume of methanol containing the same concentration of indomethacin and internal Standard at each calibration point.
The column was cleaned with acetonitrile at the end of each day and monthly with tetrahydrofuran. The column was stored in methanol.
Results
The indomethacin assay was linear for 0.5 ml of plasma using area ratios for 50 §/1 to 10 mg/1, but a four point calibration from 0.15 mg/1 to 1.0 mg/1 was used ( fig. 1) , since the patient levels of indomethacin usually feil within this ränge. The assay was repeated 10 times with a linear calibration, similar to that in figure l, obtained for the indomethacin level in 0.5 ml of plasma. The inter-assay coefficients of Variation at each point in the 10 calibration curves were: 0.15 mg/1, 8.49%; 0.30 mg/1, 6.48%; 0.50 mg/1, 5.10%; and 1.00 mg/1, 2.22%. The intra-assay coefficients of Variation at the 4 calibration points for 2 injections each of duplicate points (assay Variation) and for 10 injections of the same Standard (Integration Variation) are shown in table l. The recovery of both indomethacin and Standard was quantitative (tab. 2). Results of repeat analysis following storage of samples ät -70 °C for 2 weeks did not väry from those obtained originally. These results were all obtained using 0.5 ml of plasma and a final elution of 1.5 ml of methanol from the C« Sep-Pak. The assay was also linear for indomethacin in concentrations of 0.1 mg/1 tp 10 mg/1 in 0.5 ml of human plasma using peak heights from a strip chart recorder (data not shown). 2 ) The mean ± SD of duplicates determined in duplicate tubes (n = 4) for each concentration was used to calculate the coefficient of Variation.
3 ) The mean ± SD of ten analyses (n = 10) of the same tube for each concentration was used to calculate the coefficient of Variation. 1 ) The same amount of internal Standard (l g) and varying amounts of indomethacin were added to both 1.5ml of methanol and 0.5 ml of plasma. The plasma was processed äs outlined in the Experimental Section. Elution of internal Standard and indomethacin from Sep-Pak was carried out with 1.5 ml of methanol. The area counts of internal Standard and indomethacin recovered in the processed samples was compared directly with the respective area counts in the unprocessed methanol. 2 ) Mean of duplicates.
The Sep-Pak removed contaminants eluting in the flushthrough and also just before the internal Standard. Despite column cleaning, without Sep-Pak processing the internal Standard would Start to elute on the tail of contaminants within 30-50 analyses, making accurate quantitation increasingly difficult. The Sep-Pak cartridges improved sensitivity by stabilizing the baseline detected by the monitor and integrator. Processing 8 calibration curve samples and 14 patient plasma samples followed by HPLC analyses required a total of 16 hours.
Preliminary results have indicated that the assay sensitivity (smaller concentrations of indomethacin in plasma) can be increased by concentrating the final 1.5 ml of methanol 3-5 fold from the Sep-Pak cartridge ( fig. 2) . We have also shown in preliminary experiments that it is possible to utilize 0.1 ml of plasma, provided the final 1.5 ml of methanol are concentrated 3 -5 fold. Processing five different samples of plasma which did not contain either indomethacin or internal Standard indicated that there were no interfering substances present in the chromatogram for these two materials. Processing plasma which contained either the internal Standard or the indomethacin indicated that these materials were recovered quantitatively from the Sep-Pak cärtridge. Analysis of methanol containing dndomethacin and internal Standard yielded the same chromatogram before ( fig. 3) and after passage over the Sep-Pak cärtridge. Analysis of those plasma samples obtained from patients prior to administration of indomethacin ( fig. 4 ) yielded no indomethaoin (n = 10) compared to samples obtained following indomethacin therapy. Haemolyzed plasma can be used since no interfering substances were detected after processing.
The identification of indomethacin and the internal Standard was verified by both coinjection and dilütion of the calibration curve samples with an equal volume of methanol containing the same concentration of indomethacin and internal Standard at each calibration point. Analysis by HPLC indicated that the rest of the peaks in the chromatogram were diluted to approximately one-half of their initial area counts, while those of internal Standard and indomethacin remained the same indicating identity. 
Discussion
Modifikation of aii HPLC assay for indomethacin using Sep-Pak has resulted in increased sensitivity, lengthened column life and improved reproducibility with less frequent column cleaning. Though the use of Sep-Pak requires additional time, some sainples can be processed while others are being analyzed by HPLC. Thus, the overall tiine involved is not much longer than that required in other reported assays which do not utilize Sep-Pak. To date, we have used this method to analyze 112 samples from 16 patients with patent ductus arteriosus using 10 calibration cürves with 4 points each performed in duplicate. Patients were treated with indomethacin several times during the course öf 72 hours. A peak plasma indomethacin level of 0.500 mg/1 usually resulted in closure of the duct (unpublished observations). Reproducibility has been quite satisfactory and the initial column is still in use. Fürthermore, since many impurities are removed by Sep-Pak, the sensitivity of the monitor could be higher. This would result in even greater sensitivity since larger area counts would be obtained. The methanol employed for elution of the Sep-Pak bound indomethacin and internal Standard can be concentrated should greater sensitivity be necessary. Alternatively, indomethacin in äs little äs 100· 1 of plasma can be assayed with proper adjustment of the internal Standard and initial reagents followed by a 3 -5 fold final methanol effluent concentration. Less methanol could probably be used to elute from the Sep-Pak followed by less concentration; we are currently investigating this approach. Decreasing the plasma volume requirement for analysis is of great significance for premature infants. The l ml of blood required to generate 300 -500 of plasma is equivalent to 2.5% of the circulating blood volume of a 500 g premature infant.
Several other methodological observations appear to have improved our results. Various concentrations and combinations of acetic acid, acetonitrile, and methanol were used for processing the plasma samples both initially and with Sep-Pak in order to develop the assay. Acidification of the processed plasma and Sep-Pak cartridge with acetic acid was necessary in order to quantitatively bind the indomethacin and the internal Standard to Sep-Pak. In each new lot of Sep-Pak cartridges utilized, verification was made that all of the indomethacin and internal Standard were recovered in 1.5 ml of methanol. Occasionally, a minor adjustment may be necessary (± 0.2 ml), depending on the lot of Sep-Pak. The use of such solvents äs ethyl ether or tetrahydrofuran during the extraction or elution procedures was avoided since concentration of these solvents can lead to production and accumulation of explosive peroxides. Emulsion producing solvents were not utilized. Finally, the internal Standard, l -(p-flurobenzoyl)-5-methoxy-2-methylindole acetic acid (20) has a fluorine substitüted for the chlorine present in indomethacin, providing the internal Standard with properties (molecular weight, ionic Charge and solubility) similar but not indentical to indomethacin. This similarity may have helped in obtaining quantitative recoveries of both indomethacin and the internal Standard from Sep-Pak.
Conclusion
In summary, an HPLC assay for indomethacin in small volumes of plasma has been described utilizing Sep-Pak for processing samples. The recovery of indomethacin and the internal Standard was quantitative. As a result, the assay is ideal for both clinical management äs well äs investigational study of plasma prostaglandins and their Inhibition in premature infants. Further, preservation of the column using Sep-Pak provides a cost benefit which should, in practical terms, permit more frequent use of this analytical technique.
